In the pharmaceutical industry, timelines serve as both operational benchmarks and market signals. When sponsors announce trial starts and milestones, the investment community pays close attention. But what happens when behind-the-scenes issues, such as delays in sourcing a comparator drug, throw those timelines off track? At Clinical Services International (CSI), we have seen firsthand how comparator drug sourcing, though often underestimated, can become a critical path depe

We discuss the importance of comparator medicines in Arena International's 2023 Outsourcing in Clinical Trials handbook Our article entitled ‘Budgeting for Clinical Trials: The Importance of Comparator Medicines’ appears in the 2023 Outsourcing in Clinical Trials (OCT) handbook by Arena International. Due to the growing number of global trials, and their increasing complexity, as well as drug shortages becoming more prevalent, sourcing comparator drugs has become more difficu